Physician profile
Stephen S Ehrlich
NPI 1700862547
$5,757.13
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,497 · 2020: $967 · 2021: $1,183 · 2022: $2,111.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $4,501.77 | 2019-2022 | |
| Medtronic Vascular, INC. | $253.45 | 2019-2020 | |
| Astellas Pharma US INC | $198.00 | 2019 | |
| Abbott Laboratories | $178.47 | 2021 | |
| Edwards Lifesciences Corporation | $169.29 | 2021-2022 | |
| Boston Scientific Corporation | $155.38 | 2019-2022 | |
| Acutus Medical, INC. | $146.02 | 2020-2021 | |
| Biosense Webster, INC. | $107.19 | 2020-2022 | |
| Stereotaxis INC | $30.65 | 2022 | |
| Merck Sharp & Dohme LLC | $16.91 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Ehrlich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.